best mid stock from 12/17/2012 to 12/21/2012

Halozyme Therapeutics (HALO) had the highest return between December 17, 2012 and December 21, 2012 by a mid-cap US stock, returning 26.3%.

ASSETDATE% RETURN
Halozyme Therapeutics (HALO)
12/17/2012 - 12/21/2012
26.31%
Caesars Entertainment (CZR)
12/17/2012 - 12/21/2012
19.75%
Vera Therapeutics (VERA)
12/17/2012 - 12/21/2012
19.27%
Boyd Gaming (BYD)
12/17/2012 - 12/21/2012
17.28%
Oruka Therapeutics (ORKA)
12/17/2012 - 12/21/2012
14.71%
Materion (MTRN)
12/17/2012 - 12/21/2012
14.54%
AAR (AIR)
12/17/2012 - 12/21/2012
14.06%
SM Energy (SM)
12/17/2012 - 12/21/2012
13.04%
Axcelis Technologies (ACLS)
12/17/2012 - 12/21/2012
12.5%
Energy of Minas Gerais Co DRC (CIG.C)
12/17/2012 - 12/21/2012
12.26%
Thor Industries (THO)
12/17/2012 - 12/21/2012
11.78%
DHT (DHT)
12/17/2012 - 12/21/2012
11.72%
Mohawk Industries (MHK)
12/17/2012 - 12/21/2012
11.7%
Skyline (SKY)
12/17/2012 - 12/21/2012
10.88%
Synaptics (SYNA)
12/17/2012 - 12/21/2012
10.76%
M/I Homes (MHO)
12/17/2012 - 12/21/2012
10.75%
Vipshop (VIPS)
12/17/2012 - 12/21/2012
10.55%
Cathay General Bancorp (CATY)
12/17/2012 - 12/21/2012
10.17%
TG Therapeutics (TGTX)
12/17/2012 - 12/21/2012
10.13%
First Bancorp (FBP)
12/17/2012 - 12/21/2012
9.42%
Casella Waste Systems (CWST)
12/17/2012 - 12/21/2012
9.26%
H2O America (HTO)
12/17/2012 - 12/21/2012
9.14%
IPG Photonics (IPGP)
12/17/2012 - 12/21/2012
9.13%
Bel Fuse B (BELFB)
12/17/2012 - 12/21/2012
8.78%
Builders FirstSource (BLDR)
12/17/2012 - 12/21/2012
8.72%
Mid-cap stocks are treated as having a market cap between $2B and $10B.